[{"Assets_0_Q1_USD":318353078.0,"CommonStockSharesOutstanding_0_Q1_shares":63218476.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-35560484.0,"NetIncomeLoss_1_Q1_USD":-50574367.0,"StockholdersEquity_0_Q1_USD":224754892.0,"Ticker":"APLS","CIK":"1492422","name":"APELLIS PHARMACEUTICALS, INC.","OfficialName":"Apellis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5553923312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190507"}]